← Catalog
Research Material · Peptides
GLP3-RT
30 mg · per vial
Purity: >99%
COA status: PendingDocumentation status shown clearlyU.S.-based supportAccount-protected ordering
$149.00
Laboratory research use only
No dosing, clinical-use, safety, or efficacy guidance is provided.
Product details
A research designation for a multi-receptor incretin-pathway peptide analog.
Investigated in preclinical systems for combined GLP-1, GIP, and glucagon receptor pathway activity.
Research areas: Multi-receptor signaling · Incretin pathways · Metabolic models
Specifications
- Size
- 30 mg
- Form
- Lyophilized powder (not reconstituted)
- Category
- Peptides
- Other names
- Triple-receptor incretin analog (research designation)
- Purity
- >99%
- Documentation
- COA Status: Pending
- Intended use
- Laboratory research only